Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Bermel

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Multiple Sclerosis and Related Disorders|February 15, 2022
Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialistsGustavo Saposnik, Sanketh Andhavarapu, Óscar Fernández, et al.
Neurology|July 17, 2023
Effects of Ibudilast on Retinal Atrophy in Progressive Multiple Sclerosis Subtypes: Post Hoc Analyses of the SPRINT-MS TrialHenrik Ehrhardt, Jeffrey Lambe, Hussein Moussa, et al.
Contemporary Clinical Trials|August 14, 2016
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosisRobert J Fox, Christopher S Coffey, Merit E Cudkowicz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2017
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disabilityNicholas G LaRocca, Lynn D Hudson, Richard Rudick, et al.
The Lancet. Neurology|March 25, 2016
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort studyElena H Martinez-Lapiscina, Sam Arnow, James A Wilson, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Multiple Sclerosis and Related Disorders|February 15, 2022
Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialistsGustavo Saposnik, Sanketh Andhavarapu, Óscar Fernández, et al.
Neurology|July 17, 2023
Effects of Ibudilast on Retinal Atrophy in Progressive Multiple Sclerosis Subtypes: Post Hoc Analyses of the SPRINT-MS TrialHenrik Ehrhardt, Jeffrey Lambe, Hussein Moussa, et al.
Contemporary Clinical Trials|August 14, 2016
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosisRobert J Fox, Christopher S Coffey, Merit E Cudkowicz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2017
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disabilityNicholas G LaRocca, Lynn D Hudson, Richard Rudick, et al.
The Lancet. Neurology|March 25, 2016
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort studyElena H Martinez-Lapiscina, Sam Arnow, James A Wilson, et al.
Pageof 3